BioVie Inc. (BIVI) Discusses Topline Phase 2 ADDRESS-LC Trial Data and the Potential of Bezisterim in Long Covid - Slideshow (NASDAQ:BIVI) 2026-09-17
· seekingalpha.com
2026-09-17. The following slide deck was published by BioVie Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...